At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- GI 2.0: The Playbook | Chapter 8 | The AI-Native GI Practice
- The physician referral black hole is swallowing your growth (BPD)
- Could corporate medicine be on the way out? Inside the new federal bill (MDLinx)
- Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (The New England Journal of Medicine)
- Microbiome Holds Biomarker Predictive of CRC Recurrence (GI & Endoscopy News)
- Are You Performing Second Inspection of the Right Colon? (GI & Endoscopy News)
- The AI Is in the Scope. The Evidence Isn’t. (CDO Trends Weekly)
- Updated Diagnostic Criteria for Acute Severe Ulcerative Colitis (Medscape)
